Related Experiment Video
Updated: Jul 19, 2025

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
How Industrial Policy Could Accelerate Innovation In The Life Sciences
1James C. Robinson (james.robinson@berkeley.edu), University of California Berkeley, Berkeley, California.
The US is increasing public investment in life sciences due to high drug prices, competition from China, and vaccine successes. This policy shift impacts research, startups, and corporations to maintain global leadership.
Area of Science:
- Life Sciences
- Biotechnology
- Pharmaceuticals
Background:
- US public investment in technology industries, including life sciences, is expanding.
- Drivers include public anger over drug prices, geopolitical competition with China, and optimism from COVID-19 vaccine development.
Purpose of the Study:
- Analyze emerging innovation and industrial policy in the US life sciences sector.
- Examine policy implications for research universities, startups, and large corporations.
- Consider international competition in shaping US public policy.
Main Methods:
- Analysis of emerging innovation policies.
- Review of industrial policy instruments used globally.
- Examination of three key life science sectors: research institutions, startups/scale-ups, and large corporations.
Main Results:
- US industrial policy is adapting to address funding pressures and international competition.
- Policy instruments include grants, equity investments, tax incentives, and procurement strategies.
- The analysis covers universities, startups, and established pharmaceutical/medical device companies.
Conclusions:
- US public policy must strategically address national and international competition to sustain leadership in life sciences.
- The evolving landscape necessitates a comprehensive approach to innovation and industrial strategy.
- Understanding sector-specific dynamics is crucial for effective policy implementation.
Related Concept Videos
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Regulation
Microorganisms in Medicine and Therapeutics
Drug Control Governance: Regulatory Bodies and Their Impact
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

